Internal Medicine, Medical Oncology · San Antonio, TX
NPI
1538488424
Since 2010
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
7979 Wurzbach Rd
San Antonio, TX, 78229
Phone (210) 450-1143
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.2M
55,428 services
Medicare patients, 2024
305
Average age 70
Drug cost, 2024
$1.4M
857 prescriptions
Company payments, 2025
$28K
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Elizabeth A Bowhay-Carnes was code Q0138 (injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)), 6,120 times for 12 patients. In total Elizabeth A Bowhay-Carnes billed 55,428 services in 113 codes, and Medicare paid $1.2M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-29.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 6,120 | 12 | $0.27 | $1,636 |
| J9271 Injection, pembrolizumab, 1 mg | Office | 5,200 | 12 | $44.48 | $231K |
| J1453 Injection, fosaprepitant, 1 mg | Office | 2,550 | 15 | $0.11 | $291 |
| J0897 Injection, denosumab, 1 mg | Office | 2,400 | 14 | $20.85 | $50K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 718 | 38 | $0.09 | $63.73 |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 448 | 22 | $0.07 | $33.37 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 160 | 14 | $0.73 | $117 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 151 | 79 | $13.03 | $1,968 |
| 99214 Office E&M - Established | Office | 130 | 76 | $95.25 | $12K |
| 96413 Chemotherapy Administration | Office | 128 | 71 | $94.58 | $12K |
| 96375 Injection Administration | Office | 117 | 49 | $12.26 | $1,434 |
| 96367 Intravenous Infusion, Hydration | Office | 68 | 38 | $22.79 | $1,550 |
| J7050 Infusion, normal saline solution, 250 cc | Office | 66 | 18 | $0.52 | $34.26 |
| 99233 Hospital E&M - Subsequent | Facility | 55 | 23 | $94.42 | $5,193 |
| 96372 Injection Administration | Office | 49 | 30 | $11.62 | $570 |
By year: 2022 $613K for 46,792 services; 2023 $439K for 21,829 services; 2024 $1.2M for 55,428 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 437 | 157 | $2.90 | $1,267 |
| 80053 Clinical Chemistry | 401 | 150 | $10.19 | $4,087 |
| 88185 Surgical Pathology Examination | 397 | 12 | $15.25 | $6,053 |
| 85025 Blood Count | 397 | 155 | $7.50 | $2,976 |
| 82784 Immunoassay | 208 | 40 | $9.16 | $1,906 |
| 82728 Clinical Chemistry | 169 | 71 | $13.38 | $2,261 |
| 83540 Clinical Chemistry | 163 | 71 | $6.35 | $1,035 |
| 83550 Clinical Chemistry | 163 | 71 | $8.57 | $1,398 |
| 83615 Clinical Chemistry | 95 | 46 | $5.96 | $566 |
| 82607 Clinical Chemistry | 63 | 43 | $14.90 | $939 |
Medicare prescription drug claims, 2024
In 2024, the drug Elizabeth A Bowhay-Carnes prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 58 prescriptions and refills. In total Elizabeth A Bowhay-Carnes wrote 857 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 58 | 58 | 11 | $1,987 |
| Xarelto Rivaroxaban | 57 | 102 | 13 | $53K |
| Celecoxib Generic | 51 | 71 | 12 | $4,437 |
| Morphine Sulfate Er Morphine Sulfate | 47 | 49 | Under 11 | $3,656 |
| Eliquis Apixaban | 45 | 87 | 13 | $49K |
| Hydromorphone Hcl Generic | 37 | 37 | Under 11 | $1,331 |
| Promacta Eltrombopag Olamine | 28 | 28 | Under 11 | $522K |
| Hydroxyurea Generic | 23 | 49 | Under 11 | $997 |
| Ibuprofen Generic | 23 | 23 | Under 11 | $168 |
| Ondansetron Hcl Generic | 20 | 20 | Under 11 | $158 |
| Gabapentin Generic | 19 | 24 | Under 11 | $246 |
| Methadone Hcl Generic | 18 | 18 | Under 11 | $925 |
| Imatinib Mesylate Generic | 16 | 20 | Under 11 | $13K |
| Duloxetine Hcl Generic | 15 | 17 | Under 11 | $260 |
| Warfarin Sodium Generic | 15 | 28 | Under 11 | $92.04 |
Brand drugs: 237 claims; generic drugs: 620 claims; opioid claims: 191.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Elizabeth A Bowhay-Carnes $28K ($28K in general payments such as food, travel and fees) from 4 companies. The largest payer was Alnylam Pharmaceuticals Inc. with $26K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.